Alkermes (ALKS) Gross Profit Growth (3y) (2013 - 2026)
Alkermes (ALKS) Gross Profit Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 7.62% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 4.71% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 12.55% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 76.85% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 24.80% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 0.95% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -35.83% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 44.16% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 37.26% |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 216.56% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -35.83% |
| Dec 31, 2025 | 1.77% |
| Sep 30, 2025 | 98.94% |
| Jun 30, 2025 | 101.53% |
| Mar 31, 2025 | -6.33% |
| Dec 31, 2024 | 10.75% |
| Sep 30, 2024 | 4.12% |
| Jun 30, 2024 | 10.45% |
| Mar 31, 2024 | 2.22% |
| Dec 31, 2023 | 9.04% |
| Sep 30, 2023 | 12.92% |
| Jun 30, 2023 | 39.88% |
| Mar 31, 2023 | 4.86% |
| Dec 31, 2022 | 100.37% |
| Sep 30, 2022 | -30.51% |
| Jun 30, 2022 | -30.77% |
| Mar 31, 2022 | 7.92% |
| Dec 31, 2021 | 593.48% |
| Sep 30, 2021 | 5.33% |
| Jun 30, 2021 | 99.82% |